Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Smith

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|September 13, 2018
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase InhibitorsJustin R Harrison, Stephen Brand, Victoria Smith, et al.
Plos One|December 17, 2013
First partial skeleton of a 1.34-million-year-old Paranthropus boisei from Bed II, Olduvai Gorge, TanzaniaManuel Domínguez-Rodrigo, Travis Rayne Pickering, Enrique Baquedano, et al.
Journal of Hepatology|May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasisMarion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
Nature Medicine|September 7, 2010
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironmentVivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall, et al.
BMC Cancer|April 13, 2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialCarl Christoph Schimanski, Markus Möhler, Michael Schön, et al.
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
The Journal of Cell Biology|January 28, 2021
The deubiquitylase USP9X controls ribosomal stallingAnne Clancy, Claire Heride, Adán Pinto-Fernández, et al.
The Journal of Cell Biology|February 18, 2021
Correction: The deubiquitylase USP9X controls ribosomal stallingAnne Clancy, Claire Heride, Adán Pinto-Fernández, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|September 13, 2018
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase InhibitorsJustin R Harrison, Stephen Brand, Victoria Smith, et al.
Plos One|December 17, 2013
First partial skeleton of a 1.34-million-year-old Paranthropus boisei from Bed II, Olduvai Gorge, TanzaniaManuel Domínguez-Rodrigo, Travis Rayne Pickering, Enrique Baquedano, et al.
Journal of Hepatology|May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasisMarion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
Nature Medicine|September 7, 2010
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironmentVivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall, et al.
BMC Cancer|April 13, 2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialCarl Christoph Schimanski, Markus Möhler, Michael Schön, et al.
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
The Journal of Cell Biology|January 28, 2021
The deubiquitylase USP9X controls ribosomal stallingAnne Clancy, Claire Heride, Adán Pinto-Fernández, et al.
The Journal of Cell Biology|February 18, 2021
Correction: The deubiquitylase USP9X controls ribosomal stallingAnne Clancy, Claire Heride, Adán Pinto-Fernández, et al.
Pageof 15